Rifaximin for Treatment of Small Bowel Bacterial Overgrowth
نویسندگان
چکیده
منابع مشابه
Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
INTRODUCTION This pilot study determined the efficacy of rifaximin, a gut-directed antibiotic, in reducing chronic prostatitis (CP) and gastrointestinal (GI) symptoms in patients with CP type III. The prevalence of small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS) in patients with CP was also evaluated. MATERIALS AND METHODS Chronic prostatitis patients were recr...
متن کاملAntibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.
BACKGROUND AND OBJECTIVES Few controlled trials on antibiotic therapy for small intestinal bacterial overgrowth are available at present. Aim of the study was to assess efficacy, safety and tolerability of rifaximin with respect to metronidazole for the treatment of small intestinal bacterial overgrowth. MATERIAL AND METHODS We enrolled 142 consecutive patients with diagnosis of small intesti...
متن کاملSmall Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment.
Small bowel bacterial overgrowth (SBBO) syndrome is associated with excessive numbers of bacteria in the proximal small intestine. The pathology of this condition involves competition between the bacteria and the human host for ingested nutrients. This competition leads to intraluminal bacterial catabolism of nutrients, often with production of toxic metabolites and injury to the enterocyte. A ...
متن کاملHerbal Therapy Is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial Overgrowth
OBJECTIVE Patients with small intestine bacterial overgrowth (SIBO) have chronic intestinal and extraintestinal symptomatology which adversely affects their quality of life. Present treatment of SIBO is limited to oral antibiotics with variable success. A growing number of patients are interested in using complementary and alternative therapies for their gastrointestinal health. The objective w...
متن کاملHigh dosage rifaximin for the treatment of small intestinal bacterial overgrowth.
BACKGROUND Rifaximin is a broad spectrum non-absorbable antibiotic used for treatment of small intestinal bacterial overgrowth. Doses of 1200 mg/day showed a decontamination rate of 60% with low side-effects incidence. AIMS To assess efficacy, safety and tolerability of rifaximin 1600 mg with respect to 1200 mg/day for small intestinal bacterial overgrowth treatment. METHODS Eighty consecut...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Trends in Gastroenterology and Hepatology
سال: 2018
ISSN: 2641-1652
DOI: 10.32474/ctgh.2018.01.000115